Hydrochlorothiazide
- Product NDC
- 23155-137
- 11-digit product format
- 231550137
- Labeler code
- 23155
- Product ID
- 23155-137_d2805216-a90f-4695-8597-fdbf92f2d667
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc.
- Application
- ANDA040807
- Marketing category
- ANDA
- Marketing start
- 2011-01-03
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 23155-137-01 | 2020-08-07 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
| 23155-137-10 | 2020-08-07 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
| 23155-137-16 | 2020-08-07 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
| 23155-137-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
| 23155-137-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
| 23155-137-16 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4006-f424-e053-dadaa90a57ce | 7f1ed1a0-f422-4c47-9ce8-b5ed41736cfe |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-137-01 | EA - Each | 23155-137 | 6afbe298-27e3-4454-a028-fd93d3d0c9a7 | 1 | 2013-02-11 |